1. Home
  2. FN vs RVMD Comparison

FN vs RVMD Comparison

Compare FN & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fabrinet

FN

Fabrinet

HOLD

Current Price

$497.63

Market Cap

17.3B

Sector

Utilities

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$98.05

Market Cap

15.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FN
RVMD
Founded
1999
2014
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3B
15.2B
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
FN
RVMD
Price
$497.63
$98.05
Analyst Decision
Buy
Strong Buy
Analyst Count
8
16
Target Price
$454.43
$100.13
AVG Volume (30 Days)
622.4K
5.5M
Earning Date
02-02-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
14.80
N/A
EPS
9.70
N/A
Revenue
$3,593,227,000.00
N/A
Revenue This Year
$31.72
N/A
Revenue Next Year
$17.47
$740.40
P/E Ratio
$51.40
N/A
Revenue Growth
19.71
N/A
52 Week Low
$148.55
$29.17
52 Week High
$531.22
$124.49

Technical Indicators

Market Signals
Indicator
FN
RVMD
Relative Strength Index (RSI) 56.60 47.35
Support Level $450.42 $92.50
Resistance Level $509.00 $101.93
Average True Range (ATR) 29.25 5.84
MACD 1.15 -2.83
Stochastic Oscillator 74.81 16.58

Price Performance

Historical Comparison
FN
RVMD

About FN Fabrinet

Fabrinet provides advance-level optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advance optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advance-level of packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

Share on Social Networks: